Oestrogen-receptor-mediated transcription and the influence of co-factors and chromatin state.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17721435.
- Also identified by DOI 10.1038/nrc2211.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oestrogen receptor-alpha (ERalpha)-regulated transcription in breast cancer cells involves protein co-factors that contribute to the regulation of chromatin structure. These include co-factors with the potential to regulate histone modifications such as acetylation or methylation, and therefore the transcriptional state of target genes. Although much of the information regarding the interaction of specific co-factors with ER has been generated by studying specific promoter regions, we now have an improved understanding of the nature of these interactions and are better placed to relate these with ER activity and potentially with the activity of breast cancer drugs, including tamoxifen.
Medical subject headings
- Chromatin
- Estrogen Receptor alpha
- Transcription, Genetic